A detailed history of Gamma Investing LLC transactions in Xencor Inc stock. As of the latest transaction made, Gamma Investing LLC holds 1,813 shares of XNCR stock, worth $36,713. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,813
Previous 2,172 16.53%
Holding current value
$36,713
Previous $48.1 Million 28.6%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

SELL
$18.21 - $24.5 $6,537 - $8,795
-359 Reduced 16.53%
1,813 $34.3 Million
Q1 2024

Apr 05, 2024

BUY
$18.65 - $26.52 $24,543 - $34,900
1,316 Added 153.74%
2,172 $48.1 Million
Q4 2023

Feb 01, 2024

BUY
$16.53 - $21.42 $14,149 - $18,335
856 New
856 $16 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.21B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.